Journal of Clinical and Bioanalytical Chemistry

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-1518-081136

Perspective - Journal of Clinical and Bioanalytical Chemistry (2025) Volume 9, Issue 4

Tdm: Cornerstone of personalized drug optimization

Emily Zhang*

Department of Pharmaceutical Chemistry, Peking Union Medical College, Beijing, China

*Corresponding Author:
Emily Zhang
Department of Pharmaceutical Chemistry
Peking Union Medical College, Beijing, China.
E-mail: emily.zhang@pumc.cn

Received : 03-Nov-2025, Manuscript No. aacbc-233; Editor assigned : 05-Nov-2025, PreQC No. aacbc-233(PQ); Reviewed : 25-Nov-2025, QC No aacbc-233; Revised : 04-Dec-2025, Manuscript No. aacbc-233(R); Published : 15-Dec-2025 , DOI : 10.35841/aacbc-9.4.233

Citation: Zhang E. Tdm: Cornerstone of personalized drug optimization. aacbc. 2025;09(04):233.

Visit for more related articles at Journal of Clinical and Bioanalytical Chemistry

Introduction

Therapeutic Drug Monitoring (TDM) is rapidly transforming clinical practice by enabling a highly personalized approach to drug therapy across a wide spectrum of medical disciplines. This methodology is becoming indispensable for optimizing treatment outcomes, minimizing adverse effects, and addressing the complexities of patient-specific drug responses. By moving beyond standard dosing, TDM ensures that individuals receive tailored regimens that account for their unique physiological characteristics and disease states. Here's a look at TDM's diverse applications and its foundational role in modern healthcare. Therapeutic drug monitoring (TDM) for antibiotics is gaining significant traction, moving us towards a more personalized approach. This is crucial for optimizing treatment in critically ill patients, where standard dosing might fall short or lead to toxicity. By understanding individual pharmacokinetics, we can fine-tune dosages, aiming for maximum efficacy and minimizing adverse effects, especially in the face of growing antimicrobial resistance. It's about getting the right dose, for the right patient, at the right time [1].

TDM is becoming increasingly vital in oncology, particularly for targeted anticancer therapies. The inherent variability in drug metabolism and patient response means that a 'one-size-fits-all' approach isn't always effective. This paper from the IATDMCT Oncology Scientific Committee highlights how TDM can guide personalized dosing, optimize drug exposure, and help manage treatment-related toxicities, ultimately improving patient outcomes and tolerability of complex regimens [2].

For patients undergoing solid organ transplantation, therapeutic drug monitoring of immunosuppressants is absolutely critical. It's a delicate balance: too little drug risks organ rejection, while too much can lead to severe side effects. This review emphasizes how TDM helps tailor therapy to each patient's unique pharmacokinetic profile, ensuring optimal drug levels to maintain graft function and minimize toxicity, making it an indispensable tool in transplant medicine [3].

Managing epilepsy effectively often requires precision dosing of anti-epileptic drugs (AEDs), and that's where TDM shines. This critical review underscores that despite advances in AEDs, individual pharmacokinetic variability, drug interactions, and adherence issues make TDM an essential practice. It helps clinicians achieve optimal seizure control with the lowest possible dose, reducing adverse events and improving the quality of life for patients with epilepsy [4].

In psychiatric care, therapeutic drug monitoring of psychotropic medications is a powerful tool for individualizing treatment. Patients often respond differently to standard doses due to genetic factors, comorbidities, or concomitant medications. This update highlights how TDM helps clinicians optimize antidepressant and antipsychotic dosages, ensuring therapeutic levels are reached while mitigating side effects, which ultimately leads to better adherence and improved clinical outcomes for patients with mental health conditions [5].

The COVID-19 pandemic presented unprecedented challenges in drug management, and therapeutic drug monitoring emerged as a key strategy. This article demonstrates how TDM played a crucial role in optimizing dosages of vital medications like antivirals and immunomodulators in critically ill COVID-19 patients. With altered pharmacokinetics and potential drug interactions common in severe cases, TDM helped ensure these patients received effective drug concentrations, contributing to better clinical outcomes during a global health crisis [6].

TDM is not just a diagnostic tool; it's a cornerstone of precision medicine. This paper emphasizes how TDM bridges the gap between population-based dosing and individual patient needs. By directly measuring drug concentrations and correlating them with clinical effects, TDM allows for truly personalized drug therapy. It moves us beyond educated guesses, ensuring each patient receives the optimal dose for their unique physiology, leading to improved efficacy and reduced adverse drug reactions [7].

For inflammatory bowel disease (IBD), particularly with biologic therapies, TDM is proving invaluable. Many patients experience primary or secondary loss of response, and TDM helps differentiate between pharmacokinetic and pharmacodynamic failure. This means we can guide dose escalations, de-escalations, or even therapy switches based on actual drug levels and anti-drug antibody presence, ensuring patients receive sustained effective treatment and avoiding unnecessary expenses or delayed responses [8].

Therapeutic drug monitoring in pediatric patients presents unique challenges due to rapid developmental changes affecting pharmacokinetics and pharmacodynamics. This review emphasizes the critical need for TDM in children, especially for drugs with narrow therapeutic indices like certain antibiotics and antiepileptics. Tailoring drug dosages based on measured concentrations helps avoid underdosing (leading to treatment failure) and overdosing (resulting in toxicity), ensuring safe and effective treatment in a vulnerable population [9].

The future of therapeutic drug monitoring is exciting, moving beyond just measuring drug levels. This piece suggests we're heading towards a more integrated, predictive approach, combining advanced analytical techniques with pharmacogenomics, artificial intelligence, and real-time data. This evolution will allow for highly individualized and adaptive dosing strategies, making TDM an even more powerful tool for truly personalized medicine and optimizing patient care across various therapeutic areas [10].

These diverse applications highlight TDM's indispensable role in modern medicine, ensuring that drug therapy is not a 'one-size-fits-all' approach but rather a precisely calibrated intervention. The ongoing evolution of TDM, incorporating advanced technologies and predictive analytics, promises an even more refined and integrated approach to personalized patient care. This comprehensive strategy ultimately leads to superior treatment efficacy, enhanced patient safety, and better overall health outcomes.

Conclusion

Therapeutic Drug Monitoring (TDM) is a critical component of personalized medicine, optimizing drug therapy across a wide range of clinical scenarios. It moves beyond standard dosing by accounting for individual patient pharmacokinetics, ensuring maximum efficacy and minimal toxicity. In infectious diseases, TDM for antibiotics is crucial for critically ill patients and combating antimicrobial resistance. Oncology benefits from TDM for targeted anticancer therapies, guiding personalized dosing and managing toxicities for better patient outcomes. Transplant medicine relies on TDM of immunosuppressants to prevent rejection while avoiding severe side effects. For epilepsy, TDM of anti-epileptic drugs helps achieve optimal seizure control with reduced adverse events, addressing pharmacokinetic variability and adherence. Psychiatric care uses TDM for psychotropic medications to optimize dosages based on genetic factors and comorbidities, improving adherence and outcomes for mental health conditions. TDM also played a key role during the COVID-19 pandemic, optimizing drug dosages in critically ill patients with altered pharmacokinetics. Fundamentally, TDM is a cornerstone of precision medicine, bridging population-based dosing with individual patient needs by measuring drug concentrations and correlating them with clinical effects. In inflammatory bowel disease, TDM is invaluable for biologic therapies, distinguishing pharmacokinetic from pharmacodynamic failure to guide treatment adjustments. Pediatric patients, a vulnerable population with unique pharmacokinetic challenges, critically need TDM for drugs with narrow therapeutic indices to ensure safe and effective treatment. Looking ahead, TDM is evolving towards an integrated, predictive approach, leveraging pharmacogenomics, Artificial Intelligence (AI), and real-time data for highly individualized and adaptive dosing strategies, further enhancing personalized medicine.

References

  1. Zhi M, Xin H, Ming C. Therapeutic Drug Monitoring of Antibiotics: Current Trends and Future Perspectives. Front Pharmacol. 2023;14:1289112.

    2. Indexed at, Google Scholar, Crossref

  2. Nora W, Rémi L, Marco G. Therapeutic drug monitoring of targeted anticancer therapies in routine clinical practice: a position paper by the IATDMCT Oncology Scientific Committee. Br J Cancer. 2021;124(6):1055-1065.

    3. Indexed at, Google Scholar, Crossref

  3. Camilla K, Stephanie V, Billie CDW. Therapeutic Drug Monitoring of Immunosuppressants in Solid Organ Transplantation: A Review. Pharmaceuticals (Basel). 2022;15(3):305.

    4. Indexed at, Google Scholar, Crossref

  4. Peter NP, David JB, Blaise FB. Therapeutic Drug Monitoring of Anti-Epileptic Drugs: A Critical Review. Ther Drug Monit. 2021;43(2):162-177.

    5. Indexed at, Google Scholar, Crossref

  5. Christoph H, Nils B, H-W C. Therapeutic Drug Monitoring of Psychotropic Drugs: An Update. Pharmacopsychiatry. 2020;53(4):119-144.

    6. Indexed at, Google Scholar, Crossref

  6. Carlos M, Andrea I, Jose SdP. The Role of Therapeutic Drug Monitoring in the Management of Patients with COVID-19. J Clin Med. 2021;10(15):3316.

    7. Indexed at, Google Scholar, Crossref

  7. Billie CDW, Christoph S, Daan JT. The Contribution of Therapeutic Drug Monitoring to Precision Medicine. Ther Drug Monit. 2023;45(5):547-558.

    8. Indexed at, Google Scholar, Crossref

  8. Christian N, Christoph H, Billie CDW. Therapeutic Drug Monitoring in Inflammatory Bowel Disease. Ther Drug Monit. 2023;45(5):565-578.

    9. Indexed at, Google Scholar, Crossref

  9. Giorgio P, Claudia D, Maddalena V. Therapeutic Drug Monitoring in Paediatrics: A Focus on Antibiotics and Antiepileptics. Children (Basel). 2023;10(9):1519.

    10. Indexed at, Google Scholar, Crossref

  10. Christoph H, Daan JT, Billie CDW. Future Perspectives on Therapeutic Drug Monitoring. Ther Drug Monit. 2023;45(5):543-546.

    11. Indexed at, Google Scholar, Crossref

Get the App